新西兰肠道疾病研究数据严重缺失
Major data gap for gut disorders leaves Aotearoa in the dark
研究显示,新西兰缺乏关于肠道-大脑交互障碍(DGBI)的最新数据,仅发现四项相关研究,最晚至2002年。这些条件可能影响新西兰约三分之一的成年人,但缺乏当代数据导致无法准确评估其对医疗系统的需求和成本,估计直接医疗成本可能高达16亿新西兰元。研究强调需进行专门研究以填补数据空白。
A lack of up-to-date New Zealand research into common gut disorders means the country is effectively flying blind on conditions that may affect about 1 in 3 adults, University of Otago research suggests.
Dr. Simone Bayer and research colleagues from the University of Otago have reviewed all available evidence in Aotearoa on disorders of gut-brain interaction (DGBI)—a group of chronic conditions including irritable bowel syndrome (IBS) and functional dyspepsia. Their findings, published in the New Zealand Medical Journal, reveal a striking lack of contemporary data on how common these conditions are, who is affected and what costs they incur to our health system.
Only four New Zealand studies reporting the prevalence of DGBI were identified, with the most recent published in 2002. The studies were limited to Wellington and Dunedin, and none provided prevalence data for Māori or Pacific peoples.
"People living with these conditions can experience significant and ongoing symptoms, yet we don't have any strong contemporary evidence telling us how many New Zealanders are affected," Bayer says. "That means we are also unable to properly comprehend the scale of demand on our health system, or whether different groups of New Zealanders are experiencing these conditions and accessing care in different ways."
DGBI, formerly known as functional gastrointestinal disorders, affect the way the gut functions without an identifiable structural or organic disease being found. Symptoms can include abdominal pain, changes in bowel habits and indigestion.
Internationally, the conditions are common. Research from the United Kingdom and Australia (which both have comparable publicly funded health systems) using contemporary diagnostic criteria found that approximately 37% of adults meet the criteria for at least one DGBI.
Using U.K. estimates of direct health care costs for IBS as a conservative proxy, the researchers estimate that if one-third of New Zealand's adult population has a DGBI, direct health care costs could be about NZ$1.6 billion a year.
Bayer stresses that this is a modeled estimate, rather than a direct measurement of New Zealand's current costs. "However, even this conservative estimate points to a substantial burden. The important message is that we simply do not have the New Zealand data needed to understand the problem properly," she explains.
The researchers found the evidence gap is particularly concerning for Māori, with no study identified measuring DGBI prevalence in Māori. They say future research should be designed from the outset to produce Māori-specific estimates and be undertaken in partnership with Māori health researchers and communities.
The paper also highlights the potential economic consequences of DGBI, which can involve repeated primary care visits, specialist referrals, investigations and medication, as well as lost productivity through absenteeism, reduced productivity at work and leaving the workforce early.
Bayer says the findings demonstrate the need for dedicated research investment. "We need to know how common these conditions really are in Aotearoa, how they affect different communities and what they are costing patients and the health system," she says. "A national prevalence study, alongside a formal analysis of health care costs using New Zealand health data, would give us the evidence needed to improve diagnosis, treatment and planning."
Publication details
Simone Bayer et al., Disorders of gut–brain interaction in Aotearoa New Zealand: a long-standing evidence gap with unmeasured health and economic consequences, New Zealand Medical Journal (2026). DOI: 10.26635/6965.7608
Journal information: New Zealand Medical Journal
Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Major data gap for gut disorders leaves Aotearoa in the dark (2026, November 20) retrieved 20 November 2026 from https://medicalxpress.com/news/2026-11-major-gap-gut-disorders-aotearoa.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com